NCT00378391

European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry

European Registry on Patients With ST-Elevation MI Transferred for Mechanical Reperfusion (PCI)With a Special Focus on Upstream Use of Abciximab

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,800 (planned)
• Sponsor: Jagiellonian University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

EUROTRANSFER Registry is a prospective, international, web-based European Registry on Patients with ST-Elevation MI Transferred for Mechanical Reperfusion (PCI) with a Special Focus on Upstream Use of Abciximab. This registry is designed to collect data on approximately 1800 patients during a 12 month enrollment period in up to 20 interventional cardiology centres with hospital transfer networks from all over Europe. Analysis of this registry should allow to monitor transfer timelines of patients arriving to the cath-lab from the regional hospital with or without upstream start of abciximab and scheduled for mechanical reperfusion (PCI) as well as to monitor regional differences across Europe in regard to the impact that time of various stages of the treatment chain may have on clinical outcomes.

Conditions

• ST-Elevation Myocardial Infarction
• Acute Coronary Syndrome

Timeline

• Start date: 2005-11-01
• Completion: 2007-02-01
• First posted: 2006-09-20
• Last updated: 2007-06-20

Locations

15 sites across 7 countries: Finland, Germany, Italy, Poland, Slovenia, Spain, Sweden